Role of cytokines and chemokines in the regulation of innate immunity and HIV infection

Molecular Immunology

Volumn 42, Issue 2, 2005, Pages 161-182

  Alfano, Massimo ^a   Poli, Guido ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Chemokines; Cytokines; HIV; Innate immunity

Indexed keywords

ALPHA INTERFERON; BETA CHEMOKINE; BETA INTERFERON; CHEMOKINE; CYTOKINE; DEFENSIN; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

BASOPHIL; CELL SUBPOPULATION; DENDRITIC CELL; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNITY; INNATE IMMUNITY; MAST CELL; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 5444263178     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2004.06.016     Document Type: Short Survey

References (402)

1. I. Abbate, F. Dianzani, O. Turriziani, G. Antonelli, G. D'Offizi, V. Galati, M. Pierdominici, F. Pandolfi, and M.R. Capobianchi Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2 AIDS 15 2001 11 16
2. B. Agerberth, J. Charo, J. Werr, B. Olsson, F. Idali, L. Lindbom, R. Kiessling, H. Jornvall, H. Wigzell, and G.H. Gudmundsson The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations Blood 96 2000 3086 3093
3. C. Agrati, G. D'Offizi, P. Narciso, C. Selva, L.P. Pucillo, G. Ippolito, and F. Poccia Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic vdelta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy AIDS Res. Hum. Retrovir. 17 2001 1357 1363
4. I. Airoldi, D. Saverino, A. Favre, F. Ghiotto, C. Tacchetti, P. Facchetti, G. Piatti, G. Li Pira, D. Fenoglio, M. Duse, E. Ciccone, F. Manca, A. Plebani, C.E. Grossi, and V. Pistoia Cytokine gene expression and T-cell proliferative responses in lymph node mononuclear cells from children with early stage human immunodeficiency virus infection Haematologica 85 2000 1237 1247
5. S. Akira Mammalian Toll-like receptors Curr. Opin. Immunol. 15 2003 5 11
6. S. Akira, K. Takeda, and T. Kaisho Toll-like receptors: critical proteins linking innate and acquired immunity Nat. Immunol. 2 2001 675 680
7. R.E. Akridge, and S.G. Reed Interleukin-12 decreases human immunodeficiency virus type 1 replication in human macrophage cultures reconstituted with autologous peripheral blood mononuclear cells J. Infect. Dis. 173 1996 559 564
8. H. Aladdin, C.S. Larsen, B.K. Moller, H. Ullum, M.R. Buhl, J. Gerstoft, P. Skinhoj, and B.K. Pedersen Effects of subcutaneous interleukin-2 therapy on phenotype and function of peripheral blood mononuclear cells in human immunodeficiency virus infected patients Scand. J. Immunol. 51 2000 168 175
9. M. Alfano, and G. Poli Cytokine and chemokine based control of hiv infection and replication Curr. Pharm. Des. 7 2001 993 1013
10. M. Alfano, and G. Poli The cytokine network in HIV infection Curr. Mol. Med. 2 2002 677 689
11. L. Al-Harthi, K.A. Roebuck, and A. Landay Induction of HIV-1 replication by type 1-like cytokines, interleukin (IL)-12 and IL-15: effect on viral transcriptional activation, cellular proliferation, and endogenous cytokine production J. Clin. Immunol. 18 1998 124 131
12. P. Allavena, A. Sica, A. Vecchi, M. Locati, S. Sozzani, and A. Mantovani The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues Immunol. Rev. 177 2000 141 149
13. K. Alonso, P. Pontiggia, R. Medenica, and S. Rizzo Cytokine patterns in adults with AIDS Immunol. Invest. 26 1997 341 350
14. R.F. Ambinder Epstein-Barr virus associated lymphoproliferations in the AIDS setting Eur. J. Cancer 37 2001 1209 1216
15. P. Ancuta, Y. Bakri, N. Chomont, H. Hocini, D. Gabuzda, and N. Haeffner-Cavaillon Opposite effects of IL-10 on the ability of dendritic cells and macrophages to replicate primary CXCR4-dependent HIV-1 strains J. Immunol. 166 2001 4244 4253
16. J. Andersson, T.E. Fehniger, B.K. Patterson, J. Pottage, M. Agnoli, P. Jones, H. Behbahani, and A. Landay Early reduction of immune activation in lymphoid tissue following highly active HIV therapy AIDS 12 1998 123 129
17. H. Arase, N. Arase, and T. Saito Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking J. Exp. Med. 183 1996 2391 2396
18. W.S. Armstrong, and P. Kazanjian Use of cytokines in human immunodeficiency virus-infected patients: colony-stimulating factors, erythropoietin, and interleukin-2 Clin. Infect. Dis. 32 2001 766 773
19. J.M. Austyn Antigen-presenting cells Am. J. Respir. Crit. Care Med. 162 2000 146 150
20. B. Autran, F. Triebel, C. Katlama, W. Rozenbaum, T. Hercend, and P. Debre T cell receptor gamma/delta+ lymphocyte subsets during HIV infection Clin. Exp. Immunol. 75 1989 206 210
21. S. Ayehunie, E.A. Garcia-Zepeda, J.A. Hoxie, R. Horuk, T.S. Kupper, A.D. Luster, and R.M. Ruprecht Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors Blood 90 1997 1379 1386
22. L. Azzoni, E. Papasavvas, J. Chehimi, J.R. Kostman, K. Mounzer, J. Ondercin, B. Perussia, and L.J. Montaner Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity J. Immunol. 168 2002 5764 5770
23. E.S. Baekkevold, T. Yamanaka, R.T. Palframan, H.S. Carlsen, F.P. Reinholt, U.H. von Andrian, P. Brandtzaeg, and G. Haraldsen The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment J. Exp. Med. 193 2001 1105 1112
24. R.T. Bailer, A. Holloway, J. Sun, J.B. Margolick, M. Martin, J. Kostman, and L.J. Montaner IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression J. Immunol. 162 1999 7534 7542
25. R.T. Bailer, B. Lee, and L.J. Montaner IL-13 and TNF-alpha inhibit dual-tropic HIV-1 in primary macrophages by reduction of surface expression of CD4, chemokine receptors CCR5,CXCR4 and post-entry viral gene expression Eur. J. Immunol. 30 2000 1340 1349
26. R.A. Baiocchi, J.S. Ward, L. Carrodeguas, C.F. Eisenbeis, R. Peng, S. Roychowdhury, S. Vourganti, T. Sekula, M. O'Brien, M. Moeschberger, and M.A. Caligiuri GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder J. Clin. Invest. 108 2001 887 894
27. J. Banchereau, F. Briere, C. Caux, J. Davoust, S. Lebecque, Y.J. Liu, B. Pulendran, and K. Palucka Immunobiology of dendritic cells Annu. Rev. Immunol. 18 2000 767 811
28. J. Banchereau, S. Paczesny, P. Blanco, L. Bennett, V. Pascual, J. Fay, and A.K. Palucka Dendritic cells: controllers of the immune system and a new promise for immunotherapy Ann. N.Y. Acad. Sci. 987 2003 180 187
29. W. Barcellini, G.P. Rizzardi, J.B. Marriott, C. Fain, R.J. Shattock, P.L. Meroni, G. Poli, and A.G. Dalgleish Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumour necrosis factor (TNF)-alpha and TNF receptor type 1 in a promonocytic cell line AIDS 10 1996 835 842
30. M. Barcova, L. Kacani, C. Speth, and M.P. Dierich gp41 envelope protein of human immunodeficiency virus induces interleukin (IL)-10 in monocytes, but not in B, T, or NK cells, leading to reduced IL-2 and interferon-gamma production J. Infect. Dis. 177 1998 905 913
31. D.H. Barouch, A. Craiu, M.J. Kuroda, J.E. Schmitz, X.X. Zheng, S. Santra, J.D. Frost, G.R. Krivulka, M.A. Lifton, C.L. Crabbs, G. Heidecker, H.C. Perry, M.E. Davies, H. Xie, C.E. Nickerson, T.D. Steenbeke, C.I. Lord, D.C. Montefiori, T.B. Strom, J.W. Shiver, M.G. Lewis, and N.L. Letvin Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys Proc. Natl. Acad. Sci. U.S.A. 97 2000 4192 4197
32. D.H. Barouch, S. Santra, J.E. Schmitz, M.J. Kuroda, T.M. Fu, W. Wagner, M. Bilska, A. Craiu, X.X. Zheng, G.R. Krivulka, K. Beaudry, M.A. Lifton, C.E. Nickerson, W.L. Trigona, K. Punt, D.C. Freed, L. Guan, S. Dubey, D. Casimiro, A. Simon, M.E. Davies, M. Chastain, T.B. Strom, R.S. Gelman, D.C. Montefiori, M.G. Lewis, E.A. Emini, J.W. Shiver, and N.L. Letvin Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination Science 290 2000 486 492
33. M.A. Barron, N. Blyveis, B.E. Palmer, S. MaWhinney, and C.C. Wilson Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals J. Infect. Dis. 187 2003 26 37
34. G.M. Barton, and R. Medzhitov Control of adaptive immune responses by Toll-like receptors Curr. Opin. Immunol. 14 2002 380 383
35. M. Bayard-McNeeley, H. Doo, S. He, A. Hafner, W.D. Johnson Jr., and J.L. Ho Differential effects of interleukin-12, interleukin-15, and interleukin-2 on human immunodeficiency virus type 1 replication in vitro Clin. Diagn. Lab. Immunol. 3 1996 547 553
36. A.D. Befus, C. Mowat, M. Gilchrist, J. Hu, S. Solomon, and A. Bateman Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action J. Immunol. 163 1999 947 953
37. F. Belardelli, M. Ferrantini, E. Proietti, and J.M. Kirkwood Interferon-alpha in tumor immunity and immunotherapy Cytokine Growth Factor Rev. 13 2002 119 134
38. F. Belardelli, and I. Gresser The neglected role of type I interferon in the T-cell response: implications for its clinical use Immunol. Today 17 1996 369 372
39. A. Bendelac, M.N. Rivera, S.H. Park, and J.H. Roark Mouse CD1-specific NK1 T cells: development, specificity, and function Annu. Rev. Immunol. 15 1997 535 562
40. E.A. Berger, P.M. Murphy, and J.M. Farber Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease Annu. Rev. Immunol. 17 1999 657 700
41. A. Biragyn, I.M. Belyakov, Y.H. Chow, D.S. Dimitrov, J.A. Berzofsky, and L.W. Kwak DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses Blood 100 2002 1153 1159
42. C.A. Biron, K.B. Nguyen, G.C. Pien, L.P. Cousens, and T.P. Salazar-Mather Natural killer cells in antiviral defense: function and regulation by innate cytokines Annu. Rev. Immunol. 17 1999 189 220
43. P. Biswas, M. Ferrarini, B. Mantelli, C. Fortis, G. Poli, A. Lazzarin, and A.A. Manfredi Double-edged effect of Vgamma9/Vdelta2 T lymphocytes on viral expression in an in vitro model of HIV-1/mycobacteria co-infection Eur. J. Immunol. 33 2003 252 263
44. P. Biswas, B. Mantelli, A. Sica, M. Malnati, C. Panzeri, A. Saccani, H. Hasson, A. Vecchi, A. Saniabadi, P. Lusso, A. Lazzarin, and A. Beretta Expression of CD4 on human peripheral blood neutrophils Blood 101 2003 4452 4456
45. P. Biswas, G. Poli, A.L. Kinter, J.S. Justement, S.K. Stanley, W.J. Maury, P. Bressler, J.M. Orenstein, and A.S. Fauci Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells J. Exp. Med. 176 1992 739 750
46. C. Blank, H. Fuchs, K. Rappersberger, M. Rollinghoff, and H. Moll Parasitism of epidermal Langerhans cells in experimental cutaneous leishmaniasis with Leishmania major J. Infect. Dis. 167 1993 418 425
47. G.C. Blobe, W.P. Schiemann, and H.F. Lodish Role of transforming growth factor beta in human disease N. Engl. J. Med. 342 2000 1350 1358
48. I. Bodi, P.L. Kimmel, A.A. Abraham, L.P. Svetkey, P.E. Klotman, and J.B. Kopp Renal TGF-beta in HIV-associated kidney diseases Kidney Int. 51 1997 1568 1577
49. U. Boehm, T. Klamp, M. Groot, and J.C. Howard Cellular responses to interferon-gamma Annu. Rev. Immunol. 15 1997 749 795
50. C. Bogdan The function of type I interferons in antimicrobial immunity Curr. Opin. Immunol. 12 2000 419 424
51. M.R. Boulassel, G.H. Smith, N. Gilmore, M. Klein, T. Murphy, J. MacLeod, R. LeBlanc, J. Allan, P. Rene, R.G. Lalonde, and J.P. Routy Interleukin-7 levels maypredict virological response in advanced HIV-1-infected patients receiving lopinavir/ritonavir-based therapy HIV Med. 4 2003 315 320
52. S. Boullier, M. Cochet, F. Poccia, and M.L. Gougeon CDR3-independent gamma delta V delta 1+ T cell expansion in the peripheral blood of HIV-infected persons J. Immunol. 154 1995 1418 1431
53. S. Boullier, Y. Poquet, T. Debord, J.J. Fournie, and M.L. Gougeon Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the Vgamma9Vdelta2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons Eur. J. Immunol. 29 1999 90 99
54. J.D. Boyer, A.D. Cohen, K.E. Ugen, R.L. Edgeworth, M. Bennett, A. Shah, K. Schumann, B. Nath, A. Javadian, M.L. Bagarazzi, J. Kim, and D.B. Weiner Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids AIDS 14 2000 1515 1522
55. J.D. Boyer, A.D. Cohen, K.E. Ugen, R.L. Edgeworth, M. Bennett, A. Shah, K. Schumann, B. Nath, A. Javadian, M.L. Bagarazzi, J. Kim, and D.B. Weiner Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleuoin-12 expressing plasmiDs AIDS 14 2000 1515 1522
56. M.J. Boyle, M.F. Berger, M. Tschuchnigg, J.E. Valentine, B.G. Kennedy, M. Divjak, D.A. Cooper, J.J. Turner, R. Penny, and W.A. Sewell Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients Clin. Exp. Immunol. 92 1993 100 105
57. J.E. Brinchmann Differential responses of T cell subsets: possible role in the immunopathogenesis of AIDS AIDS 14 2000 1689 1700
58. R.R. Brutkiewicz, and R.M. Welsh Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells J. Virol. 69 1995 3967 3971
59. M.R. Burk, L. Mori, and G. De Libero Human V gamma 9-V delta 2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites Eur. J. Immunol 25 1995 2052 2058
60. C. Carini, M. Guerriero, and C. Fratazzi Modulation of TCR usage in HIV-1 infection is regulated by IL-7 and sCD23 Allergol. Immunopathol. (Madr.) 25 1997 238 246
61. K.H. Chang, J.M. Kim, N.C. Yoo, W.H. Kim, J.H. Park, I.H. Choi, H.S. Kim, K.W. Lee, Y.G. Song, S.K. Hong, and H.Y. Kim Restoration of P-glycoprotein function is involved in the increase of natural killer activity with exogenous interleukin-15 in human immunodeficiency virus-infected individuals Yonsei Med. J. 41 2000 600 606
62. T.L. Chang, F. Francois, A. Mosoian, and M.E. Klotman CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition J. Virol. 77 2003 6777 6784
63. J. Chehimi, D.E. Campbell, L. Azzoni, D. Bacheller, E. Papasavvas, G. Jerandi, K. Mounzer, J. Kostman, G. Trinchieri, and L.J. Montaner Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals J. Immunol. 168 2002 4796 4801
64. J. Chehimi, Q. Luo, L. Azzoni, L. Shawver, N. Ngoubilly, R. June, G. Jerandi, M. Farabaugh, and L.J. Montaner HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages J. Leukoc. Biol. 74 2003 757 763
65. J. Chehimi, J.D. Marshall, O. Salvucci, I. Frank, S. Chehimi, S. Kawecki, D. Bacheller, S. Rifat, and S. Chouaib IL-15 enhances immune functions during HIV infection J. Immunol. 158 1997 5978 5987
66. J. Chehimi, S.E. Starr, I. Frank, A. D'Andrea, X. Ma, R.R. MacGregor, J. Sennelier, and G. Trinchieri Impaired interleukin 12 production in human immunodeficiency virus-infected patients J. Exp. Med. 179 1994 1361 1366
67. J. Chehimi, N.M. Valiante, A. D'Andrea, M. Rengaraju, Z. Rosado, M. Kobayashi, B. Perussia, S.F. Wolf, S.E. Starr, and G. Trinchieri Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumor-derived and virus-infected cells Eur. J. Immunol. 23 1993 1826 1830
68. Z.W. Chen, and N.L. Letvin Vgamma2Vdelta2+ T cells and anti-microbial immune responses Microb. Infect. 5 2003 491 498
69. L. Chene, M.T. Nugeyre, E. Guillemard, N. Moulian, F. Barre-Sinoussi, and N. Israel Thymocyte-thymic epithelial cell interaction leads to high-level replication of human immunodeficiency virus exclusively in mature CD4(+) CD8(-) CD3(+) thymocytes: a critical role for tumor necrosis factor and interleukin-7 J. Virol. 73 1999 7533 7542
70. A. Cheret, R. Le Grand, P. Caufour, O. Neildez, F. Matheux, F. Theodoro, B. Vaslin, and D. Dormont RANTES, IFN-gamma, CCR1, and CCR5 mRNA expression in peripheral blood, lymph node, and bronchoalveolar lavage mononuclear cells during primary simian immunodeficiency virus infection of macaques Virology 255 1999 285 293
71. O. Chertov, D.F. Michiel, L. Xu, J.M. Wang, K. Tani, W.J. Murphy, D.L. Longo, D.D. Taub, and J.J. Oppenheim Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils J. Biol. Chem. 271 1996 2935 2940
72. E. Chiappini, L. Galli, C. Azzari, and M. de Martino Interleukin-7 and immunologic failure despite treatment with highly active antiretroviral therapy in children perinatally infected with HIV-1 J. Acquir. Immune Defic. Syndr. 33 2003 601 604
73. Y.K. Choi, B.A. Fallert, M.A. Murphey-Corb, and T.A. Reinhart Simian immunodeficiency virus dramatically alters expression of homeostatic chemokines and dendritic cell markers during infection in vivo Blood 101 2003 1684 1691
74. M. Clerici, D.R. Lucey, J.A. Berzofsky, L.A. Pinto, T.A. Wynn, S.P. Blatt, M.J. Dolan, C.W. Hendrix, S.F. Wolf, and G.M. Shearer Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro Science 262 1993 1721 1724
75. M. Clerici, M. Saresella, F. Colombo, S. Fossati, N. Sala, D. Bricalli, M.L. Villa, P. Ferrante, L. Dally, and A. Vigano T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV Blood 96 2000 3866 3871
76. F. Cocchi, A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo, and P. Lusso Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells Science 270 1995 1811 1815
77. A.M. Cole, T. Hong, L.M. Boo, T. Nguyen, C. Zhao, G. Bristol, J.A. Zack, A.J. Waring, O.O. Yang, and R.I. Lehrer Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1 Proc. Natl. Acad. Sci. U.S.A. 99 2002 1813 1818
78. M. Colonna, A. Krug, and M. Cella Interferon-producing cells: on the front line in immune responses against pathogens Curr. Opin. Immunol. 14 2002 373 379
79. K. Conant, A. Garzino-Demo, A. Nath, J.C. McArthur, W. Halliday, C. Power, R.C. Gallo, and E.O. Major Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia Proc. Natl. Acad. Sci. U.S.A. 95 1998 3117 3121
80. R.I. Connor, K.E. Sheridan, D. Ceradini, S. Choe, and N.R. Landau Change in coreceptor use coreceptor use correlates with disease progression in HIV-1-infected individuals J. Exp. Med. 185 1997 621 628
81. P. Constant, F. Davodeau, M.A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J.J. Fournie Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands Science 264 1994 267 270
82. R. Correa, S. Resino, and M.A. Munoz-Fernandez Increased interleukin-7 plasma levels are associated with recovery of CD4+ T cells in HIV-infected children J. Clin. Immunol. 23 2003 401 406
83. A. Craiu, D.H. Barouch, X.X. Zheng, M.J. Kuroda, J.E. Schmitz, M.A. Lifton, T.D. Steenbeke, C.E. Nickerson, K. Beaudry, J.D. Frost, K.A. Reimann, T.B. Strom, and N.L. Letvin An IL-2/Ig fusion protein influences CD4+ T lymphocytes in naive and simian immunodeficiency virus-infected Rhesus monkeys AIDS Res. Hum. Retrovir. 17 2001 873 886
84. C. Cupp, J.P. Taylor, K. Khalili, and S. Amini Evidence for stimulation of the transforming growth factor beta 1 promoter by HIV-1 Tat in cells derived from CNS Oncogene 8 1993 2231 2236
85. K.A. Daher, M.E. Selsted, and R.I. Lehrer Direct inactivation of viruses by human granulocyte defensins J. Virol. 60 1986 1068 1074
86. C.J. Dale, A. Zhao, S.L. Jones, D.B. Boyle, I.A. Ramshaw, and S.J. Kent Induction of HIV-1-specific T-helper responses and type 1 cytokine secretion following therapeutic vaccination of macaques with a recombinant fowlpoxvirus co-expressing interferon-gamma J. Med. Primatol. 29 2000 240 247
87. R.T. Davey Jr., and W.B. Capra Viral load in treatment with antiretroviral therapy and interleukin 2 JAMA 284 2000 2055 2056
88. A. De Maria, A. Ferrazin, S. Ferrini, E. Ciccone, A. Terragna, and L. Moretta Selective increase of a subset of T cell receptor gamma delta T lymphocytes in the peripheral blood of patients with human immunodeficiency virus type 1 infection J. Infect. Dis. 165 1992 917 919
89. P. De Paoli, M.T. Bortolin, S. Zanussi, A. Monzoni, C. Pratesi, and M. Giacca Changes in thymic function in HIV-positive patients treated with highly active antiretroviral therapy and interleukin-2 Clin. Exp. Immunol. 125 2001 440 446
90. P. De Paoli, D. Gennari, P. Martelli, G. Basaglia, M. Crovatto, S. Battistin, and G. Santini A subset of gamma delta lymphocytes is increased during HIV-1 infection Clin. Exp. Immunol. 83 1991 187 191
91. P. De Paoli, D. Gennari, P. Martelli, V. Cavarzerani, R. Comoretto, and G. Santini Gamma delta T cell receptor-bearing lymphocytes during Epstein-Barr virus infection J. Infect. Dis. 161 1990 1013 1016
92. A. de Paulis, G. Florio, N. Prevete, M. Triggiani, I. Fiorentino, A. Genovese, and G. Marone HIV-1 envelope gp41 peptides promote migration of human Fc epsilon RI+ cells and inhibit IL-13 synthesis through interaction with formyl peptide receptors J. Immunol. 169 2002 4559 4567
93. N. Delhem, F. Hadida, G. Gorochov, F. Carpentier, J.P. de Cavel, J.F. Andreani, B. Autran, and J.Y. Cesbron Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin J. Immunol. 161 1998 2060 2069
94. M.C. Dieu, B. Vanbervliet, A. Vicari, J.M. Bridon, E. Oldham, S. Ait-Yahia, F. Briere, A. Zlotnik, S. Lebecque, and C. Caux Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites J. Exp. Med. 188 1998 373 386
95. T.S. Dobmeyer, R. Dobmeyer, D. Wesch, E.B. Helm, D. Hoelzer, and D. Kabelitz Reciprocal alterations of Th1/Th2 function in gammadelta T-cell subsets of human immunodeficiency virus-1-infected patients Br. J. Haematol. 118 2002 282 288
96. A. Dolei, A. Biolchini, C. Serra, S. Curreli, E. Gomes, and F. Dianzani Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1alpha, MIP-1beta and RANTES beta-chemokines AIDS 12 1998 183 190
97. H. Donaghy, A. Pozniak, B. Gazzard, N. Qazi, J. Gilmour, F. Gotch, and S. Patterson Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load Blood 98 2001 2574 2576
98. C.F. d'Ostiani, G. Del Sero, A. Bacci, C. Montagnoli, A. Spreca, A. Mencacci, P. Ricciardi-Castagnoli, and L. Romani Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans Implications for initiation of T helper cell immunity in vitro and in vivo J. Exp. Med. 191 2000 1661 1674
99. O. Ducrey-Rundquist, M. Guyader, and D. Trono Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes J. Virol. 76 2002 9103 9111
100. M. Eberl, M. Hintz, A. Reichenberg, A.K. Kollas, J. Wiesner, and H. Jomaa Microbial isoprenoid biosynthesis and human gammadelta T cell activation FEBS Lett. 544 2003 4 10
101. A.D. Edwards, S.P. Manickasingham, R. Sporri, S.S. Diebold, O. Schulz, A. Sher, T. Kaisho, S. Akira, and C. Reis e Sousa Microbial recognition via Toll-like receptor-dependent and -independent pathways determines the cytokine response of murine dendritic cell subsets to CD40 triggering J. Immunol. 169 2002 3652 3660
102. M. Exley, J. Garcia, S.P. Balk, and S. Porcelli Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8-T cells J. Exp. Med. 186 1997 109 120
103. A. Fakoya, P.M. Matear, E. Filley, G.A. Rook, J. Stanford, R.J. Gilson, N. Beecham, I.V. Weller, and A. Vyakarnam HIV infection alters the production of both type 1 and 2 cytokines but does not induce a polarized type 1 or 2 state AIDS 11 1997 1445 1452
104. T.A. Fehniger, G. Herbein, H. Yu, M.I. Para, Z.P. Bernstein, W.A. O'Brien, and M.A. Caligiuri Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection J. Immunol. 161 1998 6433 6438
105. S. Feldman, D. Stein, S. Amrute, T. Denny, Z. Garcia, P. Kloser, Y. Sun, N. Megjugorac, and P. Fitzgerald-Bocarsly Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors Clin. Immunol. 101 2001 201 210
106. Y. Feng, C.C. Broder, P.E. Kennedy, and E.A. Berger HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane G protein-coupled receptor Science 272 1996 872 877
107. J. Ferbas, J. Navratil, A. Logar, and C. Rinaldo Selective decrease in human immunodeficiency virus type 1 (HIV-1)-induced alpha interferon production by peripheral blood mononuclear cells during HIV-1 infection Clin. Diagn. Lab. Immunol. 2 1995 138 142
108. G. Ferlazzo, B. Morandi, A. D'Agostino, R. Meazza, G. Melioli, A. Moretta, and L. Moretta The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells Eur. J. Immunol. 33 2003 306 313
109. E.J. Fernandez, and E. Lolis Structure, function, and inhibition of chemokines Annu. Rev. Pharmacol. Toxicol. 42 2002 469 499
110. N.C. Fernandez, A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo Nat. Med. 5 1999 405 411
111. G. Ferrari, K. King, K. Rathbun, C.A. Place, M.V. Packard, J.A. Bartlett, D.P. Bolognesi, and K.J. Weinhold IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp) Clin. Exp. Immunol. 101 1995 239 248
112. R. Fleuridor, B. Wilson, R. Hou, A. Landay, H. Kessler, and L. Al-Harthi CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection Immunology 108 2003 3 9
113. A. Foli, M.W. Saville, M.W. Baseler, and R. Yarchoan Effects of the Th1 and Th2 stimulatory cytokines interleukin-12 and interleukin-4 on human immunodeficiency virus replication Blood 85 1995 2114 2123
114. C. Fortis, S. Tasca, B. Capiluppi, and G. Tambussi Natural killer cell function in HIV-1 infected patients J. Biol. Regul. Homeost. Agents 16 2002 30 32
115. T.J. Fry, and C.L. Mackall Interleukin-7: master regulator of peripheral T-cell homeostasis? Trends Immunol. 22 2001 564 571
116. G. Galli, F. Annunziato, C. Mavilia, P. Romagnani, L. Cosmi, R. Manetti, C. Pupilli, E. Maggi, and S. Romagnani Enhanced HIV expression during Th2-oriented responses explained by the opposite regulatory effect of IL-4 and IFN-gamma of fusin/CXCR4 Eur. J. Immunol. 28 1998 3280 3290
117. S.J. Galli, M. Maurer, and C.S. Lantz Mast cells as sentinels of innate immunity Curr. Opin. Immunol. 11 1999 53 59
118. T. Ganz, and R.I. Lehrer Antimicrobial peptides of vertebrates Curr. Opin. Immunol. 10 1998 41 44
119. M.L. Garba, C.D. Pilcher, A.L. Bingham, J. Eron, and J.A. Frelinger HIV antigens can induce TGF-beta(1)-producing immunoregulatory CD8+ T cells J. Immunol. 168 2002 2247 2254
120. V.E. Garcia, P.A. Sieling, J. Gong, P.F. Barnes, K. Uyemura, Y. Tanaka, B.R. Bloom, C.T. Morita, and R.L. Modlin Single-cell cytokine analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens J. Immunol. 159 1997 1328 1335
121. T.B. Geijtenbeek, D.S. Kwon, R. Torensma, S.J. van Vliet, G.C. van Duijnhoven, J. Middel, I.L. Cornelissen, H.S. Nottet, V.N. KewalRamani, D.R. Littman, C.G. Figdor, and Y. van Kooyk DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells Cell 100 2000 587 597
122. S. Ghezzi, S. Menzo, A. Brambilla, P.P. Bordignon, A.L. Lorini, M. Clementi, G. Poli, and E. Vicenzi Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands Virology 280 2001 253 261
123. S. Ghezzi, D.M. Noonan, M.G. Aluigi, G. Vallanti, M. Cota, R. Benelli, M. Morini, J.D. Reeves, E. Vicenzi, G. Poli, and A. Albini Inhibition of CXCR4-dependent HIV-1 infection by extracellular HIV-1 Tat Biochem. Biophys. Res. Commun. 270 2000 992 996
124. L. Giavedoni, S. Ahmad, L. Jones, and T. Yilma Expression of gamma interferon by simian immunodeficiency virus increases attenuation and reduces postchallenge virus load in vaccinated rhesus macaques J. Virol. 71 1997 866 872
125. D. Gibellini, G. Zauli, M.C. Re, D. Milani, G. Furlini, E. Caramelli, S. Capitani, and M. La Placa Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially up-regulates IL-6 and TGF-beta 1 mRNA expression and protein synthesis in peripheral blood monocytes Br. J. Haematol. 88 1994 261 267
126. S. Glushakova, J.C. Grivel, K. Suryanarayana, P. Meylan, J.D. Lifson, R. Desrosiers, and L. Margolis Nef enhances human immunodeficiency virus replication and responsiveness to interleukin-2 in human lymphoid tissue ex vivo J. Virol. 73 1999 3968 3974
127. S. Glushakova, Y. Yi, J.C. Grivel, A. Singh, D. Schols, E. De Clercq, R.G. Collman, and L. Margolis Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo J. Clin. Invest. 104 1999 R7 R11
128. D. Goletti, A.L. Kinter, E.C. Hardy, G. Poli, and A.S. Fauci Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells J. Immunol. 156 1996 3501 3508
129. M. Gompels, S. Patterson, M.S. Roberts, S.E. Macatonia, A.J. Pinching, and S.C. Knight Increase in dendritic cell numbers, their function and the proportion uninfected during AZT therapy Clin. Exp. Immunol. 112 1998 347 353
130. C.J. Gordon, M.A. Muesing, A.E. Proudfoot, C.A. Power, J.P. Moore, and A. Trkola Enhancement of human immunodeficiency virus type 1 infection by the CC-chemokine RANTES is independent of the mechanism of virus-cell fusion J. Virol. 73 1999 684 694
131. A. Granelli-Piperno, B. Moser, M. Pope, D. Chen, Y. Wei, F. Isdell, U. O'Doherty, W. Paxton, R. Koup, S. Mojsov, N. Bhardwaj, I. Clark-Lewis, M. Baggiolini, and R.M. Steinman Efficient interaction of HIV-1 with purified dendritic cells via multiple chemokine coreceptors J. Exp. Med. 184 1996 2433 2438
132. F. Granucci, C. Vizzardelli, N. Pavelka, S. Feau, M. Persico, E. Virzi, M. Rescigno, G. Moro, and P. Ricciardi-Castagnoli Inducible IL-2 production by dendritic cells revealed by global gene expression analysis Nat. Immunol. 2 2001 882 888
133. F. Granucci, I. Zanoni, S. Feau, and P. Ricciardi-Castagnoli Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity EMBO J. 22 2003 2546 2551
134. C.M. Gray, L. Morris, J. Murray, J. Keeton, S. Shalekoff, S.F. Lyons, P. Sonnenberg, and D.J. Martin Identification of cell subsets expressing intracytoplasmic cytokines within HIV-1-infected lymph nodes AIDS 10 1996 1467 1475
135. C. Graziosi, K.R. Gantt, M. Vaccarezza, J.F. Demarest, M. Daucher, M.S. Saag, G.M. Shaw, T.C. Quinn, O.J. Cohen, C.C. Welbon, G. Pantaleo, and A.S. Fauci Kinetics of cytokine expression during primary human immunodeficiency virus type 1 infection Proc. Natl. Acad. Sci. U.S.A. 93 1996 4386 4391
136. C. Graziosi, G. Pantaleo, K.R. Gantt, J.P. Fortin, J.F. Demarest, O.J. Cohen, R.P. Sekaly, and A.S. Fauci Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals Science 265 1994 248 252
137. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena Antigen presentation and T cell stimulation by dendritic cells Annu. Rev. Immunol. 20 2002 621 667
138. E. Guillemard, M.T. Nugeyre, L. Chene, N. Schmitt, C. Jacquemot, F. Barre-Sinoussi, and N. Israel Interleukin-7 and infection itself by human immunodeficiency virus 1 favor virus persistence in mature CD4(+)CD8(-)CD3(+) thymocytes through sustained induction of Bcl-2 Blood 98 2001 2166 2174
139. D.W. Haas, J. Lavelle, J.P. Nadler, S.B. Greenberg, P. Frame, N. Mustafa, M. St Clair, R. McKinnis, L. Dix, M. Elkins, and J. Rooney A randomized trial of interferon alpha therapy for HIV type 1 infection AIDS Res. Hum. Retrovir. 16 2000 183 190
140. M.S. Hasan, E.G. Kallas, E.K. Thomas, J. Looney, M. Campbell, and T.G. Evans Effects of interleukin-15 on in vitro human T cell proliferation and activation J. Interferon Cytokine Res. 20 2000 119 123
141. E.F. Hays, C.H. Uittenbogaart, J.C. Brewer, L.W. Vollger, and J.A. Zack In vitro studies of HIV-1 expression in thymocytes from infants and children
142. P.A. Henkart Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules Immunity 1 1994 343 346
143. B.M. Henz, M. Maurer, U. Lippert, M. Worm, and M. Babina Mast cells as initiators of immunity and host defense Exp. Dermatol. 10 2001 1 10
144. M. Honda, K. Kitamura, K. Matsuda, Y. Yokota, N. Yamamoto, R. Mitsuyasu, J.C. Chermann, and T. Tokunaga Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterization J. Immunol. 142 1989 4248 4255
145. K. Hori, P.R. Burd, J. Kutza, K.A. Weih, and K.A. Clouse Human astrocytes inhibit HIV-1 expression in monocyte-derived macrophages by secreted factors AIDS 13 1999 751 758
146. M. Houle, M. Thivierge, C. Le Gouill, J. Stankova, and M. Rola-Pleszczynski IL-10 up-regulates CCR5 gene expression in human monocytes Inflammation 23 1999 241 251
147. R. Hu, N. Oyaizu, S. Than, V.S. Kalyanaraman, X.P. Wang, and S. Pahwa HIV-1 gp160 induces transforming growth factor-beta production in human PBMC Clin. Immunol. Immunopathol. 80 1996 283 289
148. S.S. Huang, R.L. Skolasky, G.J. Dal Pan, W. Royal 3rd, and J.C. McArthur Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study J. Neurovirol. 4 1998 324 332
149. M. Ichinose, M. Asai, K. Imai, and M. Sawada Enhancement of phagocytosis by corticostatin I (CSI) in cultured mouse peritoneal macrophages Immunopharmacology 35 1996 103 109
150. N. Imami, G.A. Hardy, M.R. Nelson, S. Morris-Jones, R. Al-Shahi, C. Antonopoulos, B. Gazzard, and F.M. Gotch Induction of HIV-1-specific T cell responses by administration of cytokines in late-stage patients receiving highly active anti-retroviral therapy Clin. Exp. Immunol. 118 1999 78 86
151. S. Imlach, C. Leen, J.E. Bell, and P. Simmonds Phenotypic analysis of peripheral blood gammadelta T lymphocytes and their targeting by human immunodeficiency virus type 1 in vivo Virology 305 2003 415 427
152. A. Isaacs, and J. Lindenmann Virus interference I. The interferon Proc. R. Soc. Lond. B: Biol. Sci. 147 1957 258 267
153. D. Jarrossay, G. Napolitani, M. Colonna, F. Sallusto, and A. Lanzavecchia Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells Eur. J. Immunol. 31 2001 3388 3393
154. J. Jason, I. Buchanan, L.K. Archibald, O.C. Nwanyanwu, M. Bell, T.A. Green, A. Eick, A. Han, D. Razsi, P.N. Kazembe, H. Dobbie, M. Midathada, and W.R. Jarvis Natural T, gammadelta, and NK cells in mycobacterial, Salmonella, and human immunodeficiency virus infections J. Infect. Dis. 182 2000 474 481
155. M.D. Johnson, and L.I. Gold Distribution of transforming growth factor-beta isoforms in human immunodeficiency virus-1 encephalitis Hum. Pathol. 27 1996 643 649
156. G.J. Jones, C. Watera, S. Patterson, A. Rutebemberwa, P. Kaleebu, J.A. Whitworth, F.M. Gotch, and J.W. Gilmour Comparative loss and maturation of peripheral blood dendritic cell subpopulations in African and non-African HIV-1-infected patients AIDS 15 2001 1657 1663
157. P. Jourdan, C. Abbal, N. Noraz, T. Hori, T. Uchiyama, J.P. Vendrell, J. Bousquet, N. Taylor, J. Pene, H. Yssel, and N. Nora IL-4 induces functional cell-surface expression of CXCR4 on human T cells J. Immunol. 160 1998 4153 4157
158. S. Joyce CD1d and natural T cells: how their properties jump-start the immune system Cell Mol. Life Sci. 58 2001 442 469
159. D. Kabelitz, and D. Wesch Role of gamma delta T-lymphocytes in HIV infection Eur. J. Med. Res. 6 2001 169 174
160. N. Kadowaki, and Y.J. Liu Natural type I interferon-producing cells as a link between innate and adaptive immunity Hum. Immunol. 63 2002 1126 1132
161. T. Kanai, E.K. Thomas, Y. Yasutomi, and N.L. Letvin IL-15 stimulates the expansion of AIDS virus-specific CTL J. Immunol. 157 1996 3681 3687
162. T. Kawamura, H. Gatanaga, D.L. Borris, M. Connors, H. Mitsuya, and A. Blauvelt Decreased stimulation of CD4+ T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells J. Immunol. 170 2003 4260 4266
163. T. Kawamura, F.O. Gulden, M. Sugaya, D.T. McNamara, D.L. Borris, M.M. Lederman, J.M. Orenstein, P.A. Zimmerman, and A. Blauvelt R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms Proc. Natl. Acad. Sci. U.S.A. 100 2003 8401 8406
164. K. Kedzierska, and S.M. Crowe Cytokines and HIV-1: interactions and clinical implications Antivir. Chem. Chemother. 12 2001 133 150
165. K. Kedzierska, S.M. Crowe, S. Turville, and A.L. Cunningham The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages Rev. Med. Virol. 13 2003 39 56
166. J. Kekow, W. Wachsman, J.A. McCutchan, M. Cronin, D.A. Carson, and M. Lotz Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection Proc. Natl. Acad. Sci. U.S.A. 87 1990 8321 8325
167. J. Kekow, W. Wachsman, J.A. McCutchan, W.L. Gross, M. Zachariah, D.A. Carson, and M. Lotz Transforming growth factor-beta and suppression of humoral immune responses in HIV infection J. Clin. Invest. 87 1991 1010 1016
168. S.J. Kent, A. Zhao, C.J. Dale, S. Land, D.B. Boyle, and I.A. Ramshaw A recombinant avipoxvirus HIV-1 vaccine expressing interferon-gamma is safe and immunogenic in macaques Vaccine 18 2000 2250 2256
169. E. Khatissian, L. Chakrabarti, and B. Hurtrel Cytokine patterns and viral load in lymph nodes during the early stages of SIV infection Res. Virol. 147 1996 181 189
170. V.P. Khatri, R.A. Baiocchi, Z.P. Bernstein, and M.A. Caligiuri Immunotherapy with low-dose interleukin-2: rationale for prevention of immune-deficiency-associated cancer Cancer J. Sci. Am. 3 Suppl. 1 1997 129 136
171. J.H. Kim, J.E. Loveland, K.V. Sitz, S. Ratto Kim, R.J. McLinden, K. Tencer, K. Davis, D.S. Burke, R.N. Boswell, R.R. Redfield, and D.L. Birx Expansion of restricted cellular immune responses to HIV-1 envelope by vaccination: IL-7 and IL-12 differentially augment cellular proliferative responses to HIV-1 Clin. Exp. Immunol. 108 1997 243 250
172. J.J. Kim, J.S. Yang, K.H. Manson, and D.B. Weiner Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-gamma, or IL-4 gene adjuvants Vaccine 19 2001 2496 2505
173. A. Kinter, A. Catanzaro, J. Monaco, M. Ruiz, J. Justement, S. Moir, J. Arthos, A. Oliva, L. Ehler, S. Mizell, R. Jackson, M. Ostrowski, J. Hoxie, R. Offord, and A.S. Fauci CC-chemokines enhance the replication of T-tropic strains of HIV-1 in CD4(+) T cells: role of signal transduction Proc. Natl. Acad. Sci. U.S.A. 95 1998 11880 11885
174. A.L. Kinter, S.M. Bende, E.C. Hardy, R. Jackson, and A.S. Fauci Interleukin 2 induces CD8+ T cell-mediated suppression of human immunodeficiency virus replication in CD4+ T cells and this effect overrides its ability to stimulate virus expression Proc. Natl. Acad. Sci. U.S.A. 92 1995 10985 10989
175. A.L. Kinter, M. Ostrowski, D. Goletti, A. Oliva, D. Weissman, K. Gantt, E. Hardy, R. Jackson, L. Ehler, and A.S. Fauci HIV replication in CD4+ T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines Proc. Natl. Acad. Sci. U.S.A. 93 1996 14076 14081
176. A.L. Kinter, G. Poli, L. Fox, E. Hardy, and A.S. Fauci HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines J. Immunol. 154 1995 2448 2459
177. S.A. Klein, J.M. Dobmeyer, T.S. Dobmeyer, M. Pape, O.G. Ottmann, E.B. Helm, D. Hoelzer, and R. Rossol Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry AIDS 11 1997 1111 1118
178. S.C. Knight, and S. Patterson Bone marrow-derived dendritic cells, infection with human immunodeficiency virus, and immunopathology Annu. Rev. Immunol. 15 1997 593 615
179. S. Kohl, M. Sigaroudinia, E.D. Charlebois, and M.A. Jacobson Interleukin-12 administered in vivo decreases human NK cell cytotoxicity and antibody-dependent cellular cytotoxicity to human immunodeficiency virus-infected cells J. Infect. Dis. 174 1996 1105 1108
180. T.R. Kollmann, M. Pettoello-Mantovani, N.F. Katopodis, M. Hachamovitch, A. Rubinstein, A. Kim, and H. Goldstein Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver Proc. Natl. Acad. Sci. U.S.A. 93 1996 3126 3131
181. G. Koopman, H. Niphuis, W. Newman, T.K. Kishimoto, V.C. Maino, and J.L. Heeney Decreased expression of IL-2 in central and effector CD4 memory cells during progression to AIDS in rhesus macaques AIDS 15 2001 2359 2369
182. M. Koot, A.H. Vos, R.P. Keet, R.E. de Goede, M.W. Dercksen, F.G. Terpstra, R.A. Coutinho, F. Miedema, and M. Tersmette HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay AIDS 6 1992 49 54
183. S. Kottilil, T.W. Chun, S. Moir, S. Liu, M. McLaughlin, C.W. Hallahan, F. Maldarelli, L. Corey, and A.S. Fauci Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function J. Infect. Dis. 187 2003 1038 1045
184. J.A. Kovacs, M. Baseler, R.J. Dewar, S. Vogel, R.T. Davey Jr., J. Falloon, M.A. Polis, R.E. Walker, R. Stevens, and N.P. Salzman Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection A preliminary study N. Engl. J. Med. 332 1995 567 575
185. J.A. Kovacs, H. Imamichi, S. Vogel, J.A. Metcalf, R.L. Dewar, M. Baseler, R. Stevens, J. Adelsberger, L. Lambert, R.T. Davey Jr., R.E. Walker, J. Falloon, M.A. Polis, H. Masur, and H.C. Lane Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression J. Infect. Dis. 182 2000 1063 1069
186. J.A. Kovacs, S. Vogel, J.M. Albert, J. Falloon, R.T. Davey Jr., R.E. Walker, M.A. Polis, K. Spooner, J.A. Metcalf, M. Baseler, G. Fyfe, and H.C. Lane Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus N. Engl. J. Med. 335 1996 1350 1356
187. A. Krivine, G. Force, J. Servan, A. Cabee, F. Rozenberg, L. Dighiero, F. Marguet, and P. Lebon Measuring HIV-1 RNA and interferon-alpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex J. Neurovirol. 5 1999 500 506
188. O. Kutsch, J. Oh, A. Nath, and E.N. Benveniste Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes J. Virol. 74 2000 9214 9221
189. A. Lafeuillade, C. Poggi, S. Chadapaud, G. Hittinger, M. Chouraqui, M. Pisapia, and E. Delbeke Pilot study of a combination of highly active antiretroviral therapy and cytokines to induce HIV-1 remission J. Acquir. Immune Defic. Syndr. 26 2001 44 55
190. V. Lafont, J. Liautard, A. Gross, J.P. Liautard, and J. Favero Tumor necrosis factor-alpha production is differently regulated in gamma delta and alpha beta human T lymphocytes J. Biol. Chem. 275 2000 19282 19287
191. H.C. Lane, J.A. Kovacs, J. Feinberg, B. Herpin, V. Davey, R. Walker, L. Deyton, J.A. Metcalf, M. Baseler, and N. Salzman Anti-retroviral effects of interferon-alpha in AIDS-associated Kaposi's sarcoma Lancet 2 1988 1218 1222
192. A. Langenkamp, M. Messi, A. Lanzavecchia, and F. Sallusto Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells Nat. Immunol. 1 2000 311 316
193. C. Lapenta, S.M. Santini, E. Proietti, P. Rizza, M. Logozzi, M. Spada, S. Parlato, S. Fais, P.M. Pitha, and F. Belardelli Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells Virology 263 1999 78 88
194. C.S. Larsen, L. Ostergard, B.K. Moller, and M.R. Buhl Subcutaneous interleukin-2 in combination with anti-retroviral therapy for treatment of HIV-1-infected subjects Scand. J. Infect. Dis. 32 2000 153 160
195. J.K. Lazdins, T. Klimkait, E. Alteri, M. Walker, K. Woods-Cook, D. Cox, G. Bilbe, R. Shipman, N. Cerletti, and G. McMaster TGF-beta: upregulator of HIV replication in macrophages Res. Virol. 142 1991 239 242
196. J.K. Lazdins, T. Klimkait, K. Woods-Cook, M. Walker, E. Alteri, D. Cox, N. Cerletti, R. Shipman, G. Bilbe, and G. McMaster In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes J. Immunol. 147 1991 1201 1207
197. T. Lehner, E. Mitchell, L. Bergmeier, M. Singh, R. Spallek, M. Cranage, G. Hall, M. Dennis, F. Villinger, and Y. Wang The role of gammadelta T cells in generating antiviral factors and beta-chemokines in protection against mucosal simian immunodeficiency virus infection Eur. J. Immunol. 30 2000 2245 2256
198. R.I. Lehrer, and T. Ganz Antimicrobial peptides in mammalian and insect host defence Curr. Opin. Immunol. 11 1999 23 27
199. R.I. Lehrer, and T. Ganz Defensins of vertebrate animals Curr. Opin. Immunol. 14 2002 96 102
200. P. Leissner, V. Calenda, M. Marigliano, K. Sanhadji, J.L. Touraine, A. Pavirani, and M. Mehtali In vitro and in vivo inhibition of HIV1 replication by retroviral transfer of interferon alpha, beta, or gamma genes: application to gene therapy of AIDS Ann. Biol. Clin. (Paris) 56 1998 167 173
201. J.M. Li, X. Shen, P.P. Hu, and X.F. Wang Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity Mol. Cell. Biol. 18 1998 110 121
202. J.W. Lillard Jr., P.N. Boyaka, O. Chertov, J.J. Oppenheim, and J.R. McGhee Mechanisms for induction of acquired host immunity by neutrophil peptide defensins Proc. Natl. Acad. Sci. U.S.A. 96 1999 651 656
203. C.L. Lin, A.K. Sewell, G.F. Gao, K.T. Whelan, R.E. Phillips, and J.M. Austyn Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis J. Exp. Med. 192 2000 587 594
204. S.J. Lin, R.L. Roberts, B.J. Ank, Q.H. Nguyen, E.K. Thomas, and E.R. Stiehm Human immunodeficiency virus (HIV) type-1 GP120-specific cell-mediated cytotoxicity (CMC) and natural killer (NK) activity in HIV-infected (HIV+) subjects: enhancement with interleukin-2(IL-2), IL-12, and IL-15 Clin. Immunol. Immunopathol. 82 1997 163 173
205. Q.H. Liu, D.A. Williams, C. McManus, F. Baribaud, R.W. Doms, D. Schols, E. De Clercq, M.I. Kotlikoff, R.G. Collman, and B.D. Freedman HIV-1 gp120 and chemokines activate ion channels in primary macrophages through CCR5 and CXCR4 stimulation Proc. Natl. Acad. Sci. U.S.A. 97 2000 4832 4837
206. H.G. Ljunggren, and K. Karre In search of the 'missing self': MHC molecules and NK cell recognition Immunol. Today 11 1990 237 244
207. A. Llano, J. Barretina, A. Gutierrez, J. Blanco, C. Cabrera, B. Clotet, and J.A. Este Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals J. Virol. 75 2001 10319 10325
208. 2+ mobilization, and enzyme release J. Immunol. 156 1996 322 327
209. M. Lotz, I. Clark-Lewis, and V. Ganu HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes J. Cell Biol. 124 1994 365 371
210. M.T. Lotze, Y.L. Matory, A.A. Rayner, S.E. Ettinghausen, J.T. Vetto, C.A. Seipp, and S.A. Rosenberg Clinical effects and toxicity of interleukin-2 in patients with cancer Cancer 58 1986 2764 2772
211. M. Loubeau, A. Ahmad, E. Toma, and J. Menezes Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15 J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16 1997 137 145
212. B. Ludewig, H.R. Gelderblom, Y. Becker, A. Schafer, and G. Pauli Transmission of HIV-1 from productively infected mature Langerhans cells to primary CD4+ T lymphocytes results in altered T cell responses with enhanced production of IFN-gamma and IL-10 Virology 215 1996 51 60
213. C.E. Mackewicz, J. Yuan, P. Tran, L. Diaz, E. Mack, M.E. Selsted, and J.A. Levy Alpha-defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors AIDS 17 2003 F23 F32
214. P.A. MacPherson, C. Fex, J. Sanchez-Dardon, N. Hawley-Foss, and J.B. Angel Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy J. Acquir. Immune Defic. Syndr. 28 2001 454 457
215. A.A. Maghazachi, and A. Al-Aoukaty Chemokines activate natural killer cells through heterotrimeric G-proteins: implications for the treatment of AIDS and cancer FASEB J. 12 1998 913 924
216. A.A. Maghazachi, A. al-Aoukaty, and T.J. Schall C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins J. Immunol. 153 1994 4969 4977
217. G. Marchetti, L. Meroni, S. Varchetta, V. Terzieva, A. Bandera, D. Manganaro, C. Molteni, D. Trabattoni, S. Fossati, M. Clerici, M. Galli, M. Moroni, F. Franzetti, and A. Gori Low-dose prolonged intermittent interleukin-2 adjuvant therapy: results of a randomized trial among human immunodeficiency virus-positive patients with advanced immune impairment J. Infect. Dis. 186 2002 606 616
218. J.D. Marshall, J. Chehimi, G. Gri, J.R. Kostman, L.J. Montaner, and G. Trinchieri The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals Blood 94 1999 1003 1011
219. F. Martini, F. Poccia, D. Goletti, S. Carrara, D. Vincenti, G. D'Offizi, C. Agrati, G. Ippolito, V. Colizzi, L.P. Pucillo, and C. Montesano Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption J. Infect. Dis. 186 2002 847 850
220. F. Martini, R. Urso, C. Gioia, A. De Felici, P. Narciso, A. Amendola, M.G. Paglia, V. Colizzi, and F. Poccia Gammadelta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy Immunology 100 2000 481 486
221. C.M. Mastroianni, G. d'Ettorre, G. Forcina, M. Lichtner, F. Mengoni, C. D'Agostino, A. Corpolongo, A.P. Massetti, and V. Vullo Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection Blood 96 2000 1979 1984
222. J.F. McDyer, M. Dybul, T.J. Goletz, A.L. Kinter, E.K. Thomas, J.A. Berzofsky, A.S. Fauci, and R.A. Seder Differential effects of CD40 ligand/trimer stimulation on the ability of dendritic cells to replicate and transmit HIV infection: evidence for CC-chemokine-dependent and -independent mechanisms J. Immunol. 162 1999 3711 3717
223. A.N. McKenzie Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13 Pharmacol. Ther. 88 2000 143 151
224. V. McKiel, Z. Gu, M.A. Wainberg, and J. Hiscott Inhibition of human immunodeficiency virus type 1 multiplication by transforming growth factor beta 1 and AZT in HIV-1-infected myeloid cells J. Interferon Cytokine Res. 15 1995 849 855
225. M. Mengozzi, C. De Filippi, P. Transidico, P. Biswas, M. Cota, S. Ghezzi, E. Vicenzi, A. Mantovani, S. Sozzani, and G. Poli Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells Blood 93 1999 1851 1857
226. D. Messmer, J.M. Jacque, C. Santisteban, C. Bristow, S.Y. Han, L. Villamide-Herrera, E. Mehlhop, P.A. Marx, R.M. Steinman, A. Gettie, and M. Pope Endogenously expressed nef uncouples cytokine and chemokine production from membrane phenotypic maturation in dendritic cells J. Immunol. 169 2002 4172 4182
227. H. Moll Dendritic cells and host resistance to infection Cell Microbiol. 5 2003 493 500
228. H. Moll, H. Fuchs, C. Blank, and M. Rollinghoff Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells Eur. J. Immunol. 23 1993 1595 1601
229. L.J. Montaner, R.T. Bailer, and S. Gordon IL-13 acts on macrophages to block the completion of reverse transcription, inhibit virus production, and reduce virus infectivity J. Leukoc. Biol. 62 1997 126 132
230. L.J. Montaner, A.G. Doyle, M. Collin, G. Herbein, P. Illei, W. James, A. Minty, D. Caput, P. Ferrara, and S. Gordon Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro J. Exp. Med. 178 1993 743 747
231. K.W. Moore, R. de Waal Malefyt, R.L. Coffman, and A. O'Garra Interleukin-10 and the interleukin-10 receptor Annu. Rev. Immunol. 19 2001 683 765
232. P.A. Moran, M.L. Diegel, J.C. Sias, J.A. Ledbetter, and J.M. Zarling Regulation of HIV production by blood mononuclear cells from HIV-infected donors: I. Lack of correlation between HIV-1 production and T cell activation AIDS Res. Hum. Retrovir. 9 1993 455 464
233. A. Moretta Natural killer cells and dendritic cells: rendezvous in abused tissues Nat. Rev. Immunol. 2 2002 957 964
234. C.T. Morita, R.A. Mariuzza, and M.B. Brenner Antigen recognition by human gamma delta T cells: pattern recognition by the adaptive immune system Springer Semin. Immunopathol. 22 2000 191 217
235. M. Moser, and K.M. Murphy Dendritic cell regulation of TH1-TH2 development Nat. Immunol. 1 2000 199 205
236. D.E. Mosier, G.R. Picchio, R.J. Gulizia, R. Sabbe, P. Poignard, L. Picard, R.E. Offord, D.A. Thompson, and J. Wilken Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants J. Virol. 73 1999 3544 3550
237. A. Motsinger, A. Azimzadeh, A.K. Stanic, R.P. Johnson, L. Van Kaer, S. Joyce, and D. Unutmaz Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells J. Virol. 77 2003 8153 8158
238. A. Motsinger, D.W. Haas, A.K. Stanic, L. Van Kaer, S. Joyce, and D. Unutmaz CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection J. Exp. Med. 195 2002 869 879
239. J.J. Mule, S. Shu, and S.A. Rosenberg The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo J. Immunol. 135 1985 646 652
240. C. Munk, G. Wei, O.O. Yang, A.J. Waring, W. Wang, T. Hong, R.I. Lehrer, N.R. Landau, and A.M. Cole The theta-defensin, retrocyclin, inhibits HIV-1 entry AIDS Res. Hum. Retrovir. 19 2003 875 881
241. P.M. Murphy, M. Baggiolini, I.F. Charo, C.A. Hebert, R. Horuk, K. Matsushima, L.H. Miller, J.J. Oppenheim, and C.A. Power International union of pharmacology XXII. Nomenclature for chemokine receptors Pharmacol. Rev. 52 2000 145 176
242. T. Nagasawa, S. Hirota, K. Tachibana, N. Takakura, S. Nishikawa, Y. Kitamura, N. Yoshida, H. Kikutani, and T. Kishimoto Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 Nature 382 1996 635 638
243. M.P. Nair, and S.A. Schwartz Reversal of human immunodeficiency virus type 1 protein-induced inhibition of natural killer cell activity by alpha interferon and interleukin-2 Clin. Diagn. Lab. Immunol. 7 2000 101 105
244. H. Nakashima, N. Yamamoto, M. Masuda, and N. Fujii Defensins inhibit HIV replication in vitro AIDS 7 1993 1129
245. H. Naora, and M.L. Gougeon Enhanced survival and potent expansion of the natural killer cell population of HIV-infected individuals by exogenous interleukin-15 Immunol. Lett. 68 1999 359 367
246. L.A. Napolitano Approaches to immune reconstitution in HIV infection Top. HIV Med. 11 2003 160 163
247. L.A. Napolitano, R.M. Grant, S.G. Deeks, D. Schmidt, S.C. De Rosa, L.A. Herzenberg, B.G. Herndier, J. Andersson, and J.M. McCune Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis Nat. Med. 7 2001 73 79
248. V. Navikas, J. Link, B. Wahren, C. Persson, and H. Link Increased levels of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) mRNA expressing blood mononuclear cells in human HIV infection Clin. Exp. Immunol. 96 1994 59 63
249. F. Niyonsaba, A. Someya, M. Hirata, H. Ogawa, and I. Nagaoka Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells Eur. J. Immunol. 31 2001 1066 1075
250. A. O'Garra Cytokines induce the development of functionally heterogeneous T helper cell subsets Immunity 8 1998 275 283
251. A. Oliva, A.L. Kinter, M. Vaccarezza, A. Rubbert, A. Catanzaro, S. Moir, J. Monaco, L. Ehler, S. Mizell, R. Jackson, Y. Li, J.W. Romano, and A.S. Fauci Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro J. Clin. Invest. 102 1998 223 231
252. J.J. Oppenheim, A. Biragyn, L.W. Kwak, and D. Yang Roles of antimicrobial peptides such as defensins in innate and adaptive immunity Ann. Rheum. Dis. 62 Suppl 2 2003 ii17 21
253. A.J. Ouellette, and M.E. Selsted Paneth cell defensins: endogenous peptide components of intestinal host defense FASEB J. 10 1996 1280 1289
254. J. Pacanowski, S. Kahi, M. Baillet, P. Lebon, C. Deveau, C. Goujard, L. Meyer, E. Oksenhendler, M. Sinet, and A. Hosmalin Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection Blood 98 2001 3016 3021
255. I.W. Park, J.F. Wang, and J.E. Groopman HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes Blood 97 2001 352 358
256. V. Patella, G. Florio, A. Petraroli, and G. Marone HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE J. Immunol. 164 2000 589 595
257. A.H. Patki, M.E. Quinones-Mateu, D. Dorazio, B. Yen-Lieberman, W.H. Boom, E.K. Thomas, and M.M. Lederman Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression J. Clin. Invest. 98 1996 616 621
258. S. Patterson, M. Helbert, N.R. English, A.J. Pinching, and S.C. Knight The effect of AZT on dendritic cell number and provirus load in the peripheral blood of AIDS patients: a preliminary study Res. Virol. 147 1996 109 114
259. S. Patterson, A. Rae, N. Hockey, J. Gilmour, and F. Gotch Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus J. Virol. 75 2001 6710 6713
260. W.E. Paul Interleukin 4: signalling mechanisms and control of T cell differentiation Ciba Found. Symp. 204 1997 208 216 (discussion 216-219)
261. W.E. Paul, and R.A. Seder Lymphocyte responses and cytokines Cell 76 1994 241 251
262. L. Pedroza-Martins, K.B. Gurney, B.E. Torbett, and C.H. Uittenbogaart Differential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level J. Virol. 72 1998 9441 9452
263. L.P. Perera, C.K. Goldman, and T.A. Waldmann IL-15 induces the expression of chemokines and their receptors in T lymphocytes J. Immunol. 162 1999 2606 2612
264. M.K. Perera, R. Carter, R. Goonewardene, and K.N. Mendis Transient increase in circulating gamma/delta T cells during Plasmodium vivax malarial paroxysms J. Exp. Med. 179 1994 311 315
265. P.Y. Perera, T.N. Mayadas, O. Takeuchi, S. Akira, M. Zaks-Zilberman, S.M. Goyert, and S.N. Vogel CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression J. Immunol. 166 2001 574 581
266. O. Perrella, P.B. Carreiri, A. Perrella, C. Sbreglia, F. Gorga, D. Guarnaccia, and G. Tarantino Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): possible relationship with cerebral viral load? Eur. Cytokine Netw. 12 2001 51 55
267. M. Peruzzi, C. Azzari, M.E. Rossi, M. De Martino, and A. Vierucci Inhibition of natural killer cell cytotoxicity and interferon gamma production by the envelope protein of HIV and prevention by vasoactive intestinal peptide AIDS Res. Hum. Retrovir. 16 2000 1067 1073
268. G.R. Picchio, R.J. Gulizia, K. Wehrly, B. Chesebro, and D.E. Mosier The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes J. Virol. 72 1998 2002 2009
269. V. Poaty-Mavoungou, F.S. Toure, C. Tevi-Benissan, and E. Mavoungou Enhancement of natural killer cell activation and antibody-dependent cellular cytotoxicity by interferon-alpha and interleukin-12 in vaginal mucosae Sivmac251-infected Macaca fascicularis Viral Immunol. 15 2002 197 212
270. F. Poccia, L. Battistini, B. Cipriani, G. Mancino, F. Martini, M.L. Gougeon, and V. Colizzi Phosphoantigen-reactive Vgamma9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines J. Infect. Dis. 180 1999 858 861
271. F. Poccia, S. Boullier, H. Lecoeur, M. Cochet, Y. Poquet, V. Colizzi, J.J. Fournie, and M.L. Gougeon Peripheral V gamma 9/V delta 2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons J. Immunol. 157 1996 449 461
272. F. Poccia, M.L. Gougeon, C. Agrati, C. Montesano, F. Martini, C.D. Pauza, P. Fisch, M. Wallace, and M. Malkovsky Innate T-cell immunity in HIV infection: the role of Vgamma9Vdelta2 T lymphocytes Curr. Mol. Med. 2 2002 769 781
273. Poggi, A., Carosio, R., Fenoglio, D., Brenci, S., Murdaca, G., Setti, M., Indiveri, F., Scabini, S., Ferrero, E., Zocchi, M.R., 2003. Migration of V{delta}1 and V{delta}2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1 infected patients: competition by HIV-1 TAT. Blood.
274. A. Poggi, R. Carosio, G.M. Spaggiari, C. Fortis, G. Tambussi, G. Dell'Antonio, E. Dal Cin, A. Rubartelli, and M.R. Zocchi NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calcium-calmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain J. Immunol. 168 2002 95 101
275. M.A. Poles, S. Barsoum, W. Yu, J. Yu, P. Sun, J. Daly, T. He, S. Mehandru, A. Talal, M. Markowitz, A. Hurley, D. Ho, and L. Zhang Human immunodeficiency virus type 1 induces persistent changes in mucosal and blood gammadelta T cells despite suppressive therapy J. Virol. 77 2003 10456 10467
276. G. Poli, P. Biswas, and A.S. Fauci Interferons in the pathogenesis and treatment of human immunodeficiency virus infection Antiviral Res. 24 1994 221 233
277. G. Poli, A.L. Kinter, J.S. Justement, P. Bressler, J.H. Kehrl, and A.S. Fauci Transforming growth factor beta suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage J. Exp. Med. 173 1991 589 597
278. G. Poli, A.L. Kinter, J.S. Justement, P. Bressler, J.H. Kehrl, and A.S. Fauci Retinoic acid mimics transforming growth factor beta in the regulation of human immunodeficiency virus expression in monocytic cells Proc. Natl. Acad. Sci. U.S.A. 89 1992 2689 2693
279. G. Poli, J.M. Orenstein, A. Kinter, T.M. Folks, and A.S. Fauci Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines Science 244 1989 575 577
280. W. Popik, and P.M. Pitha Exploitation of cellular signaling by HIV-1: unwelcome guests with master keys that signal their entry Virology 276 2000 1 6
281. S.A. Porcelli, and R.L. Modlin The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids Annu. Rev. Immunol. 17 1999 297 329
282. P. Portales, J. Reynes, V. Pinet, R. Rouzier-Panis, V. Baillat, J. Clot, and P. Corbeau Interferon-alpha restores HIV-induced alteration of natural killer cell perforin expression in vivo AIDS 17 2003 495 504
283. B. Pulendran, P. Kumar, C.W. Cutler, M. Mohamadzadeh, T. Van Dyke, and J. Banchereau Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo J. Immunol. 167 2001 5067 5076
284. M.G. Quaranta, B. Mattioli, F. Spadaro, E. Straface, L. Giordani, C. Ramoni, W. Malorni, and M. Viora HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells FASEB J. 17 2003 2025 2036
285. M.G. Quaranta, E. Tritarelli, L. Giordani, and M. Viora HIV-1 Nef induces dendritic cell differentiation: a possible mechanism of uninfected CD4(+) T cell activation Exp. Cell Res. 275 2002 243 254
286. M.E. Quinones-Mateu, M.M. Lederman, Z. Feng, B. Chakraborty, J. Weber, H.R. Rangel, M.L. Marotta, M. Mirza, B. Jiang, P. Kiser, K. Medvik, S.F. Sieg, and A. Weinberg Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication AIDS 17 2003 F39 F48
287. M.F. Rabbi, A. Finnegan, L. Al-Harthi, S. Song, and K.A. Roebuck Interleukin-10 enhances tumor necrosis factor-alpha activation of HIV-1 transcription in latently infected T cells J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 19 1998 321 331
288. F. Re, and J.L. Strominger Toll-like receptor 2 (TLR2) and TLR4
289. M. Relloso, A. Puig-Kroger, O.M. Pello, J.L. Rodriguez-Fernandez, G. de la Rosa, N. Longo, J. Navarro, M.A. Munoz-Fernandez, P. Sanchez-Mateos, and A.L. Corbi DC-SIGN (CD209) expression is IL-4 dependent and is negatively regulated by IFN, TGF-beta, and anti-inflammatory agents J. Immunol. 168 2002 2634 2643
290. C.R. Rinaldo Jr. Modulation of major histocompatibility complex antigen expression by viral infection Am. J. Pathol. 144 1994 637 650
291. M.J. Robertson Role of chemokines in the biology of natural killer cells J. Leukoc. Biol. 71 2002 173 183
292. A.H. Rook, J.J. Hooks, G.V. Quinnan, H.C. Lane, J.F. Manischewitz, A.M. Macher, H. Masur, A.S. Fauci, and J.Y. Djeu Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism J. Immunol. 134 1985 1503 1507
293. D. Rossi, and A. Zlotnik The biology of chemokines and their receptors Annu. Rev. Immunol. 18 2000 217 242
294. C. Roussilhon, M. Agrapart, J.J. Ballet, and A. Bensussan T lymphocytes bearing the gamma delta T cell receptor in patients with acute Plasmodium falciparum malaria J. Infect. Dis. 162 1990 283 285
295. A. Rubartelli, A. Poggi, R. Sitia, and M.R. Zocchi HIV-I Tat: a polypeptide for all seasons Immunol. Today 19 1998 543 545
296. A. Rubbert, C. Combadiere, M. Ostrowski, J. Arthos, M. Dybul, E. Machado, M.A. Cohn, J.A. Hoxie, P.M. Murphy, A.S. Fauci, and D. Weissman Dendritic cells express multiple chemokine receptors used as coreceptors for HIV entry J. Immunol. 160 1998 3933 3941
297. J. Ruby, C. Brinkman, S. Jones, and I. Ramshaw Response of monkeys to vaccination with recombinant vaccinia virus which coexpress HIV gp160 and human interleukin-2 Immunol. Cell Biol. 68 Pt 2 1990 113 117
298. E. Ruiz-Mateos, R. de la Rosa, J.M. Franco, M. Martinez-Moya, A. Rubio, N. Soriano, A. Sanchez-Quijano, E. Lissen, and M. Leal Endogenous IL-7 is associated with increased thymic volume in adult HIV-infected patients under highly active antiretroviral therapy AIDS 17 2003 947 954
299. H. Saeki, A.M. Moore, M.J. Brown, and S.T. Hwang Cutting edge: secondary lymphoid-tissue chemokine (SLC) and CC chemokine receptor 7 (CCR7) participate in the emigration pathway of mature dendritic cells from the skin to regional lymph nodes J. Immunol. 162 1999 2472 2475
300. J.K. Sandberg, N.M. Fast, E.H. Palacios, G. Fennelly, J. Dobroszycki, P. Palumbo, A. Wiznia, R.M. Grant, N. Bhardwaj, M.G. Rosenberg, and D.F. Nixon Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection J. Virol. 76 2002 7528 7534
301. K. Sanhadji, P. Leissner, R. Firouzi, F. Pelloquin, L. Kehrli, M. Marigliano, V. Calenda, M. Ottmann, J.C. Tardy, M. Mehtali, and J.L. Touraine Experimental gene therapy: the transfer of Tat-inducible interferon genes protects human cells against HIV-1 challenge in vitro and in vivo in severe combined immunodeficient mice AIDS 11 1997 977 986
302. S.M. Santini, C. Lapenta, M. Logozzi, S. Parlato, M. Spada, T. Di Pucchio, and F. Belardelli Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice J. Exp. Med. 191 2000 1777 1788
303. A. Sartori, X. Ma, G. Gri, L. Showe, D. Benjamin, and G. Trinchieri Interleukin-12: an immunoregulatory cytokine produced by B cells and antigen-presenting cells Methods 11 1997 116 127
304. B.E. Sawaya, P. Thatikunta, L. Denisova, J. Brady, K. Khalili, and S. Amini Regulation of TNFalpha and TGFbeta-1 gene transcription by HIV-1 Tat in CNS cells J. Neuroimmunol. 87 1998 33 42
305. F. Scalise, R. Gerli, G. Castellucci, F. Spinozzi, G.M. Fabietti, S. Crupi, L. Sensi, R. Britta, R. Vaccaro, and A. Bertotto Lymphocytes bearing the gamma delta T-cell receptor in acute toxoplasmosis Immunology 76 1992 668 670
306. T.J. Schall, and K.B. Bacon Chemokines, leukocyte trafficking, and inflammation Curr. Opin. Immunol. 6 1994 865 873
307. T.M. Scharton, and P. Scott Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice J. Exp. Med. 178 1993 567 577
308. H. Schmidtmayerova, B. Sherry, and M. Bukrinsky Chemokines and HIV replication Nature 382 1996 767
309. N. Schmitt, L. Chene, D. Boutolleau, M.T. Nugeyre, E. Guillemard, P. Versmisse, C. Jacquemot, F. Barre-Sinoussi, and N. Israel Positive regulation of CXCR4 expression and signaling by interleukin-7 in CD4+ mature thymocytes correlates with their capacity to favor human immunodeficiency X4 virus replication J. Virol. 77 2003 5784 5793
310. D. Schols, and E. De Clercq Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production J. Virol. 70 1996 4953 4960
311. J.M. Schroder Epithelial antimicrobial peptides: innate local host response elements Cell Mol. Life Sci. 56 1999 32 46
312. H. Schuitemaker, N.A. Kootstra, M.H. Koppelman, S.M. Bruisten, H.G. Huisman, M. Tersmette, and F. Miedema Proliferation-dependent HIV-1 infection of monocytes occurs during differentiation into macrophages J. Clin. Invest. 89 1992 1154 1160
313. E. Schwartz, R. Shapiro, S. Shina, and I. Bank Delayed expansion of V delta 2+ and V delta 1+ gamma delta T cells after acute Plasmodium falciparum and Plasmodium vivax malaria J. Allergy Clin. Immunol. 97 1996 1387 1392
314. D.D. Scripture-Adams, D.G. Brooks, Y.D. Korin, and J.A. Zack Interleukin-7 induces expression of latent human immunodeficiency virus type 1 with minimal effects on T-cell phenotype J. Virol. 76 2002 13077 13082
315. R.A. Seder, K.H. Grabstein, J.A. Berzofsky, and J.F. McDyer Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15 J. Exp. Med. 182 1995 1067 1077
316. S. Sei, H. Akiyoshi, J. Bernard, D.J. Venzon, C.H. Fox, D.J. Schwartzentruber, B.D. Anderson, J.B. Kopp, B.U. Mueller, and P.A. Pizzo Dynamics of virus versus host interaction in children with human immunodeficiency virus type 1 infection J. Infect. Dis. 173 1996 1485 1490
317. C. Servet, L. Zitvogel, and A. Hosmalin Dendritic cells in innate immune responses against HIV Curr. Mol. Med. 2 2002 739 756
318. M.H. Shah, R.A. Baiocchi, T.A. Fehniger, V.P. Khatri, M. Gould, B. Poiesz, Z.P. Bernstein, and M.A. Caligiuri Cytokine replacement in patients with HIV-1 non-Hodgkin's lymphoma: the rationale for low-dose interleukin-2 therapy Cancer J. Sci. Am. 6 Suppl. 1 2000 S45 S51
319. S. Shalekoff, and C.T. Tiemessen Circulating levels of stromal cell-derived factor 1alpha and interleukin 7 in HIV type 1 infection and pulmonary tuberculosis are reciprocally related to CXCR4 expression on peripheral blood leukocytes AIDS Res. Hum. Retrovir. 19 2003 461 468
320. H.D. Shin, C. Winkler, J.C. Stephens, J. Bream, H. Young, J.J. Goedert, T.R. O'Brien, D. Vlahov, S. Buchbinder, J. Giorgi, C. Rinaldo, S. Donfield, A. Willoughby, S.J. O'Brien, and M.W. Smith Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10 Proc. Natl. Acad. Sci. U.S.A. 97 2000 14467 14472
321. F.P. Siegal, P. Fitzgerald-Bocarsly, B.K. Holland, and M. Shodell Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection AIDS 15 2001 1603 1612
322. M.C. Sirianni, I.J. Ansotegui, F. Aiuti, and H. Wigzell Natural killer cell stimulatory factor (NKSF)/IL-12 and cytolytic activities of PBL/NK cells from human immunodeficiency virus type-1 infected patients Scand. J. Immunol. 40 1994 83 86
323. K.A. Smith Interleukin 2 Annu. Rev. Immunol. 2 1984 319 333
324. M.D. Smithgall, J.G. Wong, K.E. Critchett, and O.K. Haffar IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells J. Immunol. 156 1996 2324 2330
325. Z. Smit-McBride, J.J. Mattapallil, M. McChesney, D. Ferrick, and S. Dandekar Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes J. Virol. 72 1998 6646 6656
326. R.J. Smyth, Y. Yi, A. Singh, and R.G. Collman Determinants of entry cofactor utilization and tropism in a dualtropic human immunodeficiency virus type 1 primary isolate J. Virol. 72 1998 4478 4484
327. E.J. Soilleux, L.S. Morris, G. Leslie, J. Chehimi, Q. Luo, E. Levroney, J. Trowsdale, L.J. Montaner, R.W. Doms, D. Weissman, N. Coleman, and B. Lee Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro J. Leukoc. Biol. 71 2002 445 457
328. V. Soumelis, I. Scott, Y.J. Liu, and J. Levy Natural type 1 interferon producing cells in HIV infection Hum. Immunol. 63 2002 1206 1212
329. A.E. Sousa, A.F. Chaves, M. Doroana, F. Antunes, and R.M. Victorino Kinetics of the changes of lymphocyte subsets defined by cytokine production at single cell level during highly active antiretroviral therapy for HIV-1 infection J. Immunol. 162 1999 3718 3726
330. S. Sozzani, P. Allavena, A. Vecchi, and A. Mantovani Chemokines and dendritic cell traffic J. Clin. Immunol. 20 2000 151 160
331. S. Sozzani, S. Ghezzi, G. Iannolo, W. Luini, A. Borsatti, N. Polentarutti, A. Sica, M. Locati, C. Mackay, T.N. Wells, P. Biswas, E. Vicenzi, G. Poli, and A. Mantovani Interleukin 10 increases CCR5 expression and HIV infection in human monocytes J. Exp. Med. 187 1998 439 444
332. H.J. Stellbrink, F.T. Hufert, K. Tenner-Racz, J. Lauer, C. Schneider, H. Albrecht, P. Racz, and J. van Lunzen Kinetics of productive and latent HIV infection in lymphatic tissue and peripheral blood during triple-drug combination therapy with or without additional interleukin-2 Antivir. Ther. 3 1998 209 214
333. G. Tambussi, S. Ghezzi, S. Nozza, G. Vallanti, L. Magenta, M. Guffanti, A. Brambilla, E. Vicenzi, P. Carrera, S. Racca, L. Soldini, N. Gianotti, M. Murone, F. Veglia, G. Poli, and A. Lazzarin Efficacy of low-dose intermittent subcutaneous interleukin (IL) - 2 in antiviral drug - experienced human immunodeficiency virus-infected persons with detectable virus load: a controlled study of 3 il-2 regimens with antiviral drug therapy J. Infect. Dis. 183 2001 1476 1484
334. Y. Tanaka, C.T. Morita, E. Nieves, M.B. Brenner, and B.R. Bloom Natural and synthetic non-peptide antigens recognized by human gamma delta T cells Nature 375 1995 155 158
335. Y.Q. Tang, J. Yuan, G. Osapay, K. Osapay, D. Tran, C.J. Miller, A.J. Ouellette, and M.E. Selsted A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins Science 286 1999 498 502
336. M. Taniguchi, and T. Nakayama Recognition and function of Valpha14 NKT cells Semin. Immunol. 12 2000 543 550
337. S. Tasca, G. Tambussi, S. Nozza, B. Capiluppi, M.R. Zocchi, L. Soldini, F. Veglia, G. Poli, A. Lazzarin, and C. Fortis Escape of monocyte-derived dendritic cells of HIV-1 infected individuals from natural killer cell-mediated lysis AIDS 17 2003 2291 2298
338. M.C. Territo, T. Ganz, M.E. Selsted, and R. Lehrer Monocyte-chemotactic activity of defensins from human neutrophils J. Clin. Invest. 84 1989 2017 2020
339. G. Trinchieri Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity Annu. Rev. Immunol. 13 1995 251 276
340. G. Trinchieri Immunobiology of interleukin-12 Immunol. Res. 17 1998 269 278
341. G. Trinchieri Proinflammatory and immunoregulatory functions of interleukin-12 Int. Rev. Immunol. 16 1998 365 396
342. K. Tsukaguchi, K.N. Balaji, and W.H. Boom CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production J. Immunol. 154 1995 1786 1796
343. Y. Tsunetsugu-Yokota, Y. Morikawa, M. Isogai, A. Kawana-Tachikawa, T. Odawara, T. Nakamura, F. Grassi, B. Autran, and A. Iwamoto Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs J. Virol. 77 2003 10250 10259
344. S.J. Turley, K. Inaba, W.S. Garrett, M. Ebersold, J. Unternaehrer, R.M. Steinman, and I. Mellman Transport of peptide-MHC class II complexes in developing dendritic cells Science 288 2000 522 527
345. C.H. Uittenbogaart, D.J. Anisman, B.D. Jamieson, S. Kitchen, I. Schmid, J.A. Zack, and E.F. Hays Differential tropism of HIV-1 isolates for distinct thymocyte subsets in vitro AIDS 10 1996 F9 16
346. C.H. Uittenbogaart, D.J. Anisman, J.A. Zack, A. Economides, I. Schmid, and E.F. Hays Effects of cytokines on HIV-1 production by thymocytes Thymus 23 1994 155 175
347. C.H. Uittenbogaart, W.J. Boscardin, D.J. Anisman-Posner, P.S. Koka, G. Bristol, and J.A. Zack Effect of cytokines on HIV-induced depletion of thymocytes in vivo AIDS 14 2000 1317 1325
348. D. Unutmaz NKT cells and HIV infection Microb. Infect. 5 2003 1041 1047
349. W.J. Urba, R.G. Steis, D.L. Longo, W.C. Kopp, A.E. Maluish, L. Marcon, D.L. Nelson, H.C. Stevenson, and J.W. Clark Immunomodulatory properties and toxicity of interleukin 2 in patients with cancer Cancer Res. 50 1990 185 192
350. Valdez, H., Lederman, M.M., 1997. Cytokines and cytokine therapies in HIV infection. AIDS Clin. Rev., 187-228.
351. A. Valentin, W. Lu, M. Rosati, R. Schneider, J. Albert, A. Karlsson, and G.N. Pavlakis Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression Proc. Natl. Acad. Sci. U.S.A. 95 1998 8886 8891
352. A. Valentin, and G.N. Pavlakis Natural killer cells are persistently infected and resistant to direct killing by HIV-1 Anticancer Res. 23 2003 2071 2075
353. A. Valentin, M. Rosati, D.J. Patenaude, A. Hatzakis, L.G. Kostrikis, M. Lazanas, K.M. Wyvill, R. Yarchoan, and G.N. Pavlakis Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy Proc. Natl. Acad. Sci. U.S.A. 99 2002 7015 7020
354. H.J. van der Vliet, B.M. von Blomberg, M.D. Hazenberg, N. Nishi, S.A. Otto, B.H. van Benthem, M. Prins, F.A. Claessen, A.J. van den Eertwegh, G. Giaccone, F. Miedema, R.J. Scheper, and H.M. Pinedo Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection J. Immunol. 168 2002 1490 1495
355. S. Van Wetering, S.P. Mannesse-Lazeroms, J.H. Dijkman, and P.S. Hiemstra Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production J. Leukoc. Biol. 62 1997 217 226
356. A. Vecchi, L. Massimiliano, S. Ramponi, W. Luini, S. Bernasconi, R. Bonecchi, P. Allavena, M. Parmentier, A. Mantovani, and S. Sozzani Differential responsiveness to constitutive vs. inducible chemokines of immature and mature mouse dendritic cells J. Leukoc. Biol. 66 1999 489 494
357. K. Vermeire, and D. Schols Specific CD4 down-modulating compounds with potent anti-HIV activity J. Leukoc. Biol. 74 2003 667 675
358. E. Vicenzi, M. Alfano, S. Ghezzi, A. Gatti, F. Veglia, A. Lazzarin, S. Sozzani, A. Mantovani, and G. Poli Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1alpha, and MCP-3, and enhancement by MCP-1 J. Leukoc. Biol. 68 2000 405 412
359. V. Vieillard, S. Jouveshomme, N. Leflour, E. Jean-Pierre, P. Debre, E. De Maeyer, and B. Autran Transfer of human CD4(+) T lymphocytes producing beta interferon in Hu-PBL-SCID mice controls human immunodeficiency virus infection J. Virol. 73 1999 10281 10288
360. F. Villinger, S.S. Brar, G.T. Brice, N.F. Chikkala, F.J. Novembre, A.E. Mayne, S. Bucur, C.D. Hillyer, and A.A. Ansari Immune and hematopoietic parameters in HIV-1-infected chimpanzees during clinical progression toward AIDS J. Med. Primatol. 26 1997 11 18
361. F. Villinger, S. Bucur, N.F. Chikkala, S.S. Brar, P. Bostik, A.E. Mayne, J. Adams, M.E. Lee, F.J. Novembre, M.K. Gately, A.A. Ansari, and C.D. Hillyer In vitro and in vivo responses to interleukin 12 are maintained until the late SIV infection stage but lost during AIDS AIDS Res. Hum. Retrovir. 16 2000 751 763
362. M. Vitale, A. Caruso, M.A. De Francesco, L. Rodella, L. Bozzo, E. Garrafa, M. Grassi, G. Gobbi, A. Cacchioli, and S. Fiorentini HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines Br. J. Haematol. 120 2003 337 343
363. T. von der Weid, A.M. Beebe, D.C. Roopenian, and R.L. Coffman Early production of IL-4 and induction of Th2 responses in the lymph node originate from an MHC class I-independent CD4+NK1.1-T cell population J. Immunol. 157 1996 4421 4427
364. M. Vulcano, N. Galassi, M. Felippo, D. Vernava, and S. Olabuenaga Interleukin-2 restores natural killer activity inhibited by sera from HIV+ hemophilic patients Medicina (B. Aires) 59 1999 162 166
365. S.M. Wahl, J.B. Allen, N. McCartney-Francis, M.C. Morganti-Kossmann, T. Kossmann, L. Ellingsworth, U.E. Mai, S.E. Mergenhagen, and J.M. Orenstein Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome J. Exp. Med. 173 1991 981 991
366. T.A. Waldmann T-cell receptors for cytokines: targets for immunotherapy of leukemia/lymphoma Ann. Oncol. 11 Suppl. 1 2000 101 106
367. T.A. Waldmann, and Y. Tagaya The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens Annu. Rev. Immunol. 17 1999 19 49
368. M. Wallace, S.R. Bartz, W.L. Chang, D.A. Mackenzie, C.D. Pauza, and M. Malkovsky Gamma delta T lymphocyte responses to HIV Clin. Exp. Immunol. 103 1996 177 184
369. M. Wallace, A.M. Scharko, C.D. Pauza, P. Fisch, K. Imaoka, S. Kawabata, K. Fujihashi, H. Kiyono, Y. Tanaka, B.R. Bloom, and M. Malkovsky Functional gamma delta T-lymphocyte defect associated with human immunodeficiency virus infections Mol. Med. 3 1997 60 71
370. H. Wang, N.J. English, C.D. Reid, J.E. Merson, and S.C. Knight Role of beta-chemokines in HIV-1 infection of dendritic cells maturing from CD34+ stem cells J. Acquir. Immune Defic. Syndr. 21 1999 179 188
371. J. Wang, E. Guan, G. Roderiquez, V. Calvert, R. Alvarez, and M.A. Norcross Role of tyrosine phosphorylation in ligand-independent sequestration of CXCR4 in human primary monocytes-macrophages J. Biol. Chem. 276 2001 49236 49243
372. J. Wang, E. Guan, G. Roderiquez, and M.A. Norcross Inhibition of CCR5 expression by IL-12 through induction of beta-chemokines in human T lymphocytes J. Immunol. 163 1999 5763 5769
373. J. Wang, E. Guan, G. Roderiquez, and M.A. Norcross Synergistic induction of apoptosis in primary CD4(+) T cells by macrophage-tropic HIV-1 and TGF-beta1 J. Immunol. 167 2001 3360 3366
374. J. Wang, G. Roderiquez, T. Oravecz, and M.A. Norcross Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression J. Virol. 72 1998 7642 7647
375. W. Wang, A.M. Cole, T. Hong, A.J. Waring, and R.I. Lehrer Retrocyclin, an antiretroviral theta-defensin, is a lectin J. Immunol. 170 2003 4708 4716
376. N. Watanabe, J.P. Sypek, S. Mittler, K.A. Reimann, P. Flores-Villanueva, G. Voss, C.I. Lord, and N.L. Letvin Administration of recombinant human interleukin 12 to chronically SIVmac-infected rhesus monkeys AIDS Res. Hum. Retrovir. 14 1998 393 399
377. J. Wedemeyer, M. Tsai, and S.J. Galli Roles of mast cells and basophils in innate and acquired immunity Curr. Opin. Immunol. 12 2000 624 631
378. M. Weiden, N. Tanaka, Y. Qiao, B.Y. Zhao, Y. Honda, K. Nakata, A. Canova, D.E. Levy, W.N. Rom, and R. Pine Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein beta expression J. Immunol. 165 2000 2028 2039
379. D. Weissman, M. Dybul, M.B. Daucher, R.T. Davey Jr., R.E. Walker, and J.A. Kovacs Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivo J. Infect. Dis. 181 2000 933 938
380. D. Weissman, G. Poli, and A.S. Fauci Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus AIDS Res. Hum. Retrovir. 10 1994 1199 1206
381. D. Weissman, G. Poli, and A.S. Fauci IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9 1995 442 449
382. D. Wesch, D. Kabelitz, K. Friese, and K. Pechhold Mycobacteria-reactive gamma delta T cells in HIV-infected individuals: lack of V gamma 9 cell responsiveness is due to deficiency of antigen-specific CD4 T helper type 1 cells Eur. J. Immunol. 26 1996 557 562
383. C.C. Wilson, W.C. Olson, T. Tuting, C.R. Rinaldo, M.T. Lotze, and W.J. Storkus HIV-1-specific CTL responses primed in vitro by blood-derived dendritic cells and Th1-biasing cytokines J. Immunol. 162 1999 3070 3078
384. S.B. Wilson, S.C. Kent, H.F. Horton, A.A. Hill, P.L. Bollyky, D.A. Hafler, J.L. Strominger, and M.C. Byrne Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes Proc. Natl. Acad. Sci. U.S.A. 97 2000 7411 7416
385. S. Worku, G.J. Gorse, R.B. Belshe, and D.F. Hoft Canarypox vaccines induce antigen-specific human gammadelta T cells capable of interferon-gamma production J. Infect. Dis. 184 2001 525 532
386. H. Xiao, C. Neuveut, H.L. Tiffany, M. Benkirane, E.A. Rich, P.M. Murphy, and K.T. Jeang Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1 Proc. Natl. Acad. Sci. U.S.A. 97 2000 11466 11471
387. D. Yang, A. Biragyn, L.W. Kwak, and J.J. Oppenheim Mammalian defensins in immunity: more than just microbicidal Trends Immunol. 23 2002 291 296
388. D. Yang, Q. Chen, O. Chertov, and J.J. Oppenheim Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells J. Leukoc. Biol. 68 2000 9 14
389. D. Yang, O. Chertov, S.N. Bykovskaia, Q. Chen, M.J. Buffo, J. Shogan, M. Anderson, J.M. Schroder, J.M. Wang, O.M. Howard, and J.J. Oppenheim Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6 Science 286 1999 525 528
390. D. Yang, O. Chertov, and J.J. Oppenheim Participation of mammalian defensins and cathelicidins in anti-microbial immunity: receptors and activities of human defensins and cathelicidin (LL-37) J. Leukoc. Biol. 69 2001 691 697
391. Y.F. Yang, M. Tomura, M. Iwasaki, T. Mukai, P. Gao, S. Ono, J.P. Zou, G.M. Shearer, H. Fujiwara, and T. Hamaoka IL-12 as well as IL-2 upregulates CCR5 expression on T cell receptor-triggered human CD4+ and CD8+ T cells J. Clin. Immunol. 21 2001 116 125
392. D. Zagury, A. Lachgar, V. Chams, L.S. Fall, J. Bernard, J.F. Zagury, B. Bizzini, A. Gringeri, E. Santagostino, J. Rappaport, M. Feldman, A. Burny, and R.C. Gallo Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS Proc. Natl. Acad. Sci. U.S.A. 95 1998 3851 3856
393. L. Zamai, M. Ahmad, I.M. Bennett, L. Azzoni, E.S. Alnemri, and B. Perussia Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells J. Exp. Med. 188 1998 2375 2380
394. S. Zanussi, C. Simonelli, M.T. Bortolin, M. D'Andrea, C. Crepaldi, E. Vaccher, G. Nasti, D. Politi, L. Barzan, U. Tirelli, and P. De Paoli Immunological changes in peripheral blood and in lymphoid tissue after treatment of HIV-infected subjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2 Clin. Exp. Immunol. 116 1999 486 492
395. S. Zanussi, C. Simonelli, M.T. Bortolin, M. D'Andrea, C. Crepaldi, E. Vaccher, G. Nasti, D. Politi, L. Barzan, U. Tirelli, and P. De Paoli Immunological changes in peripheral blood and in lymphoid tissue after treetment of HIV-infected sUbjects with highly active anti-retroviral therapy (HAART) or HAART + IL-2 Clin. Exp. Immunol. 116 1999 486 492
396. G. Zauli, B.R. Davis, M.C. Re, G. Visani, G. Furlini, and M. La Placa Tat protein stimulates production of transforming growth factor-beta 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression Blood 80 1992 3036 3043
397. B. Zerhouni, K. Sanhadji, L. Kehrli, J.M. Livrozet, and J.L. Touraine Interleukin (IL)-2 deficiency aggravates the defect of natural killer cell activity in AIDS patients Thymus 24 1997 147 156
398. L. Zhang, W. Yu, T. He, J. Yu, R.E. Caffrey, E.A. Dalmasso, S. Fu, T. Pham, J. Mei, J.J. Ho, W. Zhang, P. Lopez, and D.D. Ho Contribution of human alpha-defensin 1,2 and 3 to the anti-HIV-1 activity of CD8 antiviral factor Science 298 2002 995 1000
399. X. Zhang, S. Sun, I. Hwang, D.F. Tough, and J. Sprent Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15 Immunity 8 1998 591 599
400. W. Zou, A. Coulomb, A. Venet, A. Foussat, D. Berrebi, C. Beyer, M.C. Crevon, A. Minty, A. Couedel-Courteille, E. Vivier, F. Capron, P. Galanaud, and D. Emilie Administration of interleukin 13 to simian immunodeficiency virus-infected macaques: induction of intestinal epithelial atrophy AIDS Res. Hum. Retrovir. 14 1998 775 783
401. W. Zou, A. Foussat, S. Houhou, I. Durand-Gasselin, A. Dulioust, L. Bouchet, P. Galanaud, Y. Levy, and D. Emilie Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2, ANRS 048 IL-2 Study Group AIDS 13 1999 455 463
402. Y.R. Zou, A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development Nature 393 1998 595 599